2026-10-11T05:39:25Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34015954 2026-09-28T17:26:45Z category_146 category_7 category_12 category_21 category_272 category_46 category_734 category_106 category_132 category_134 portal_5 item_type_3 month_year_09_2026

<p>Baseline values and change from baseline of tear volume by Schirmer’s test in SCAI-001 0.01%, SCAI-001 0.02%, and Restasis group at 4, 8, and 12 weeks.</p> Jae Hyun Kim (665252) Hui Kyung Kim (25132606) Young-Joo Shin (717790) Chul Young Choi (9107235) Hong Kyun Kim (6560315) Eunchul Kim (1633903) Jae Yong Kim (6919850) Ji Eun Lee (407595) SunWoong Kim (25132609) Moonwon Hwang (10808881) Jong-Seok Song (9121904) Dong Hyun Kim (184121) Jong Soo Lee (2380816) Space Science Medicine Cell Biology Biotechnology Environmental Sciences not elsewhere classified Immunology Biological Sciences not elsewhere classified Science Policy Infectious Diseases Virology phase 2 trial dry eye disease conjunctival staining improved achieved earlier improvements 05 %) emulsion primary efficacy endpoint osdi scores improved corneal surface scores 02 %) compared excluding 4 weeks xlink "> low 01 %, scai xlink "> 02 %, 12 weeks time point tear volume study aimed group difference greater extent cyclosporine 0 comparative study clinical effectiveness 001 0 <p>Baseline values and change from baseline of tear volume by Schirmer’s test in SCAI-001 0.01%, SCAI-001 0.02%, and Restasis group at 4, 8, and 12 weeks.</p> 2026-09-28T17:26:20Z Dataset Dataset 10.1371/journal.pone.0358007.t002 https://figshare.com/articles/dataset/_p_Baseline_values_and_change_from_baseline_of_tear_volume_by_Schirmer_s_test_in_SCAI-001_0_01_SCAI-001_0_02_and_Restasis_group_at_4_8_and_12_weeks_p_/34015954 CC BY 4.0